by Leslie Small
For health insurers that operate in the Affordable Care Act
exchanges, 2022 is shaping up to be a relatively stable, profitable year with
few regulatory surprises, health policy experts tell AIS Health. Still, there
will be some regulatory uncertainty that plans must grapple with as well as a
newly proposed rule effective in 2023 that imposes tighter controls on benefits
and network design than even the Obama administration attempted.
Standardized plans will make a splash
- That regulation is the Notice of Benefit and Payment
Parameters (NBPP) 2023 Proposed Rule, released by the Biden administration on Dec. 28.
Perhaps the biggest change included in the annual omnibus exchange rule —
the move to require standardized ACA marketplace plans — was already known to the industry but still promises to make a
significant impact.
- Under the Obama administration, insurers were not
forced to offer such plans, but they did get preferential display on
HealthCare.gov. Now, insurers must offer a standardized plan at every
product, network type and metal level, and throughout every service area,
where they also offer non-standardized options. Plus, such plans will get
preferential display.
- Another major proposed change in the 2023 NBPP is the
administration’s move to resume evaluating the adequacy of provider
networks offered by qualified health plans on the federal exchange.
CMS takes ‘strong stance’ on discriminatory benefits
- Perhaps the most unexpected part of the NBPP is CMS’s
proposal to create a “clear regulatory framework” for identifying
discriminatory benefit design. That’s according to Katie Keith, a health
care attorney and research professor who writes the Health Affairs series
“Following the ACA.”
- For example, plans will no longer be able to restrict
coverage for things like hearing aids and in vitro fertilization based on
age, unless clinically indicated, or for gender-affirming care for
transgender individuals. In addition, the proposed rule will reinstate
protections to ensure that LGBTQ+ people are explicitly protected from
discrimination by exchanges, states, insurers, and agents and
brokers.
- “It’s going to be hugely important,” Keith says of the
new requirements. “This is a really strong stance that they’re taking,
that all of this stuff has to be justified medically.”
- ACA exchange insurers, she predicts, are “going to have
to do a lot of work to look at their benefits and their exclusions, and
some of their clinical utilization management techniques” to evaluate
whether they’re truly evidence based.
No comments:
Post a Comment